123 related articles for article (PubMed ID: 5343403)
1. Antibacterial effects of G 30'320 Geigy (B663) in lepromatous leprosy.
Hastings RC; Trautman JR; Mansfield RE
Dermatol Int; 1969; 8(1):21-7. PubMed ID: 5343403
[No Abstract] [Full Text] [Related]
2. Controlled clinical trial of clofazimine in untreated lepromatous leprosy.
Karat AB; Jeevaratnam A; Karat S; Rao PS
Br Med J; 1971 Nov; 4(5786):514-6. PubMed ID: 4942741
[TBL] [Abstract][Full Text] [Related]
3. Forty-four months' experience in the treatment of leprosy with clofazimine (Lamprene (Geigy)).
Schulz EJ
Lepr Rev; 1971 Sep; 42(3):178-87. PubMed ID: 5151819
[No Abstract] [Full Text] [Related]
4. Effects of the administration of B663 [G 30 320, Lamprene, clofazimine (Geigy)] on three groups of lepromatous and borderline of leprosy.
Rodriguez JN; Abalos RM; Reich CV; Tolentino JG
Int J Lepr Other Mycobact Dis; 1974; 42(3):276-88. PubMed ID: 4617715
[No Abstract] [Full Text] [Related]
5. Efficacy of clofazimine in the prophylaxis and suppression of reactive phases of lepromatous leprosy.
Karat AB; Jeevaratnam A; Karat S; Rao PS
Int J Lepr Other Mycobact Dis; 1971; 39(4):838-41. PubMed ID: 5170472
[No Abstract] [Full Text] [Related]
6. Chemotherapeutic trials in leprosy. 3. Pilot trial of a riminophenazine derivative. B.663, in the treatment of lepromatous leprosy.
Pettit JH; Rees RJ; Ridley DS
Int J Lepr Other Mycobact Dis; 1967; 35(1):25-33. PubMed ID: 5336368
[No Abstract] [Full Text] [Related]
7. [. 663 (G 30320 "Geigy"), a new chemotherapeutic agent against leprosy].
Vischer WA
Schweiz Med Wochenschr; 1967 Mar; 97(10):308. PubMed ID: 5585384
[No Abstract] [Full Text] [Related]
8. The treatment of erythema nodosum leprosum with B.663. A controlled study.
Pettit JH
Int J Lepr Other Mycobact Dis; 1967; 35(1):11-6. PubMed ID: 4290017
[No Abstract] [Full Text] [Related]
9. A treatment of corticosteroid-dependent lepromatous patients in persistent erythema nodosum leprosum. A clinical evaluation of G.30320 (B663).
Imkamp FM
Lepr Rev; 1968 Jul; 39(3):119-25. PubMed ID: 4298736
[No Abstract] [Full Text] [Related]
10. Treatment of moderately severe erythema nodosum leprosum with clofazimine--a controlled trial.
Helmy HS; Pearson JM; Waters MF
Lepr Rev; 1971 Sep; 42(3):167-77. PubMed ID: 4339652
[No Abstract] [Full Text] [Related]
11. Clofazimine (B663, Geigy) in leprosy reactions.
Smith RB
Australas J Dermatol; 1972 Apr; 13(1):31-5. PubMed ID: 5082494
[No Abstract] [Full Text] [Related]
12. Chemotherapeutic trials in leprosy. 5. A study of methods used in clinical trials in lepromatous leprosy.
Waters MF; Rees RJ; Sutherland I
Int J Lepr Other Mycobact Dis; 1967; 35(3):311-35. PubMed ID: 4917107
[No Abstract] [Full Text] [Related]
13. Clofazimine therapy of lepromatous leprosy caused by dapsone-resistant mycobacterium leprae.
Levy L; Shepard CC; Fasal P
Am J Trop Med Hyg; 1972 May; 21(3):315-21. PubMed ID: 4554496
[No Abstract] [Full Text] [Related]
14. Controlled long-term therapy of leprosy with B663 (lamprene, clofazimine) compared with DDS.
Tolentino JG; Rodriquez JN; Abalos RM
Int J Lepr Other Mycobact Dis; 1974; 42(4):416-418. PubMed ID: 4617720
[No Abstract] [Full Text] [Related]
15. A preliminary report on the use of B663 in the treatment of Chinese leprosy patients with chronic reaction.
Warren AG
Lepr Rev; 1968 Apr; 39(2):61-6. PubMed ID: 5653308
[No Abstract] [Full Text] [Related]
16. Thymus-dependent lymphocytes of peripheral blood in leprosy patients.
Lim SD; Kiszkiss DF; Jacobson RR; Choi YS; Good RA
Infect Immun; 1974 Feb; 9(2):394-9. PubMed ID: 4544619
[TBL] [Abstract][Full Text] [Related]
17. Double-blind controlled clinical trial of clofazimine in reactive phases of lepromatous leprosy.
Karat AB; Jeevaratnam A; Karat S; Rao PS
Br Med J; 1970 Jan; 1(5690):198-200. PubMed ID: 4904935
[TBL] [Abstract][Full Text] [Related]
18. Dapsone alone compared with dapsone plus rifampicin in short-term therapy of lepromatous leprosy.
Gelber RH; Waters MF; Pearson JM; Rees RJ; McDougall AC
Lepr Rev; 1977 Dec; 48(4):223-9. PubMed ID: 400806
[No Abstract] [Full Text] [Related]
19. [Activity of B663 in lepromatous leprosy. Therapeutic trial].
Pene P; Carrie J; Bourgeade A; Bolliot Y
Bull Soc Pathol Exot Filiales; 1971; 64(4):407-15. PubMed ID: 5172361
[No Abstract] [Full Text] [Related]
20. 'B 663' POSSIBLE ANTI-INFLAMMATORY ACTION IN LEPROMATOUS LEPROSY.
BROWNE SG
Lepr Rev; 1965 Jan; 36():9-11. PubMed ID: 14241920
[No Abstract] [Full Text] [Related]
[Next] [New Search]
